NEONATAL RENOVASCULAR HYPERTENSION AND TARGET-ORGAN DAMAGE

Authors

  • Ana Cristóvão Ferreira Interna de Formação Especializada em Pediatria Médica, Serviço de Pediatria Médica, Departamento de Pediatria, Hospital de Santa Maria - Centro Hospitalar Universitário de Lisboa Norte, EPE
  • Mónica Rebelo Assistente graduada em Cardiologia Pediátrica, Serviço de Cardiologia Pediátrica, Departamento de Pediatria, Hospital de Santa Maria - Centro Hospitalar de Lisboa Norte, EPE
  • Luísa Lobo Assistente graduada em Radiologia, Serviço de Imagiologia, Hospital de Santa Maria -Centro Hospitalar Universitário de Lisboa Norte, EPE
  • Carla Simão Assistente graduada em Pediatria Médica, Área de Hipertensão do Serviço de Pediatria, Serviço de Pediatria Médica, Departamento de Pediatria, Hospital de Santa Maria - Centro Hospitalar Universitário de Lisboa Norte, EPE; Faculdade de Medicina da Universidade de Lisboa

DOI:

https://doi.org/10.58043/rphrc.27

Keywords:

Neonatal, Secondary hypertension (renovascular), Target-organ damage

Abstract

Introduction: Arterial hypertension in the neonatal period is defined by blood pressure values above the 95th percentile, taking into account post-menstrual age. At this age group, it is usually due to renal disease (parenchymal or renovascular diseases). The target-organ lesion may be present at these ages; however, it can be potentially reversible, if the diagnosis and the therapeutic intervention are made in a timely manner and orientated to the cause.

Case description: Female term newborn, second child of young and non-blood related parents, diabetic mother (type II diabetes mellitus); in which feeding difficulties, hyporreactivity and high blood pressure values were detected by the 3rd day of life. The cardiac evaluation, with an echocardiogram, revealed an important impairment of biventricular function, dilation of the right cavities and left ventricular hypertrophy. The initial renal function analytic assessment was normal and the renal Doppler ultrasound pointed out a left renal artery’s stenosis. The abdominal computed tomography angiography confirmed stenosis and obliteration of the left renal artery, with reduced vascular patency and lack of homolateral kidney perfusion. A catheterization was performed to clarify the aetiology and as an attempt to solve the clinical situation. It brought up the hypothesis of obstruction by a thrombus, whereby she started therapy with low molecular weight heparin. The hypotensive treatment, initially intravenously, was on the 17th day of life replaced to oral treatment, with gradual improvement and control of blood pressure values. She was discharged at the 30th day of life, with multidisciplinary follow-up and with blood pressure values controlled. The cardiac reassessment, at the time of discharge, revealed a regression of the changes initially described. Nephrological progression revealed loss of function of the left kidney, compatible with the presence of functionally significant stenosis of the left renal artery. She underwent left nephrectomy at nine months of life. The anatomopathological evaluation was compatible with the clinical diagnosis of left renal artery stenosis, likely because of artery’s hypoplasia. She keeps being followed up and currently, she is no longer under hypotensive treatment.

Discussion: The neonatal hypertension is a rare condition, usually associated to a secondary cause, which most of times are treatable. A target-organ lesion can arise in early ages as the neonatal period. An early and adequate approach allows the reversal of the findings, with a good prognosis.

Downloads

Download data is not yet available.

References

Espírito Santo R, Simão C. Hipertensão arterial no recém- nascido. In: ACSM, ed. Protocolos de Urgência Em Pediatria. 4a edição. ; 2019:273-275.

Inamura N, Sato M. Neonatal renovascular hypertension. Pediatr Int. 2018;60(5):501. doi:10.1111/ped.13549

Starr MC, Flynn JT. Neonatal hypertension: cases, causes, and clinical approach. Pediatr Nephrol. 2019;34(5):787-799. doi:10.1007/s00467-018-3977-4

Batisky DL. Neonatal Hypertension. Clin Perinatol. 2014;41(3):529-542. doi:10.1016/j.clp.2014.05.004

Alves I, Martins T, Neves AL, et al. Should first blood pressure measurement be performed in the newborn ? Rev Port Cardiol (English Ed. 2018;37(7):625.e1-625.e5. doi:10.1016/j. repce.2017.03.012

Chung H, Lee JH, Park E, et al. Long-Term Outcomes of Pediatric Renovascular Hypertension. Kidney Blood Press Res. 2017;(42):617-627. doi:10.1159/000481549

Ramaswamy P, Schulman S, Filipov P, Kupferman JC. Unmasking of neonatal renovascular hypertension by milrinone used for cardiac dysfunction. Pediatr Cardiol. 2011;32(7):998-1000. doi:10.1007/s00246-011-0027-4

Deitrick J, Stevenson K, Nguyen D, Sessions W, Linga V, Vasylyeva T. Hypertension secondary to renal hypoplasia presenting as acute heart failure in a newborn. Clin Hypertens. 2019;25(1):1-5. doi:10.1186/s40885-019-0115-y

Sharma D, Farahbakhsh N, Shastri S, Sharma P. Neonatal hypertension. J Matern Neonatal Med. 2017;30(5):540-550. doi:10.1 080/14767058.2016.1177816

Flynn JT. Causes of hypertension in neonates. Pediatr Nephrol. 2000;14:332-341.

Gleason CA, Devaskar SU. Renal Vascular Disease in the Newborn. In: Avery’s Diseases of the Newborn. 9th ed. ; 2012:1239- 1244.

Jerónimo M, Dionísio T, Gomes C, Neves JF. Renovascular hypertension: A case with atypical neurological signs. BMJ Case Rep. 2015;2015:1-4. doi:10.1136/bcr-2014-208336

Daehnert I, Hennig B, Scheinert D. Percutaneous transluminal angioplasty for renovascular hypertension in a neonate. Clin Obs. 2004:1149-1152. doi:10.1080/08035250410023610

Harer MW, Kent AL. Neonatal hypertension: an educational review. Pediatr Nephrol. 2019;34(6):1009-1018. doi:10.1007/s00467-018-3996-1

Martin RJ, Fanaroff AA, Walsh MC. The cardiovascular system. In: Fanaroff and MArtin’s Neonatal-Perinatal Medicine. 9th ed. ; 2011:1268-1269.

Flynn JT. Hypertension in the neonatal period. Curr Opin Pediatr. 2012;24(2). doi:10.1097/MOP.0b013e32834f8329

McTaggart SJ, Gelati S, Walker RG, Powell HR, Jones CL. Evaluation and long-term outcome of pediatric: Renovascular hypertension. Pediatr Nephrol. 2000;14(10-11):1022-1029. doi:10.1007/s004670050066

Agrawal H, Moodie D, Qureshi AM, et al. Interventions in children with renovascular hypertension: A 27-year retrospective single-center experience. Congenit Heart Dis. 2018;13(3):349-356. doi:10.1111/chd.12608

Wilson DI, Appleton RE, Coulthard MG, Lee REJ, Wren C, Bain HH. Fetal and infantile hypertension caused by unilateral renal arteries disease. Arch Dis Child. 1990;65(8):881-884. doi:10.1136/adc.65.8.881

Hegde S, Wright C, Shenoy M, Moghal NE, Coulthard MG. Renovascular hypertension commencing during fetal life. Arch Dis Child Fetal Neonatal Ed. 2007;92(4):301-305. doi:10.1136/ adc.2006.104919

Published

2022-05-28

How to Cite

1.
Cristóvão Ferreira A, Rebelo M, Lobo L, Simão C. NEONATAL RENOVASCULAR HYPERTENSION AND TARGET-ORGAN DAMAGE. RH [Internet]. 2022 May 28 [cited 2024 Dec. 18];(84):18-24. Available from: https://revistahipertensao.pt/index.php/rh/article/view/27

Issue

Section

Caso Clínico